Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cellu Tears
- Development stage
- Unknown
- Lead developer
- Grevis Pharma
- Modality
- Small Molecules
- Administration
- Ophthalmic, Topical
01
Overview
Cellu Tears is a carboxymethylcellulose-based ophthalmic lubricant product line developed and manufactured by Grevis Pharma in India. The formulation contains sodium carboxymethylcellulose (CMC), typically at concentrations of 0.5% to 1%, which serves as a viscoelastic artificial tear substitute. CMC works by increasing tear viscosity and supplementing the pre-corneal tear film, providing a protective and lubricating shield over the ocular surface. This mechanism offers temporary relief from burning, irritation, and discomfort caused by dry eye syndrome or exposure to environmental factors. Cellu Tears is available in multiple topical formats, including eye drops and gel preparations, and is classified as a non-systemic medical device or lubricant.
- Brand names
- Cellu TearsCellu-Tears-Gel
- Other names
- Carboxymethylcellulose eye dropsSodium carboxymethylcellulose lubricantCMC eye drops
Beyond the preview
Go deeper on Cellu Tears.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellu Tears.